Table 3.
Study Group (n = 28) | Control Group (n = 26) | ||||||
---|---|---|---|---|---|---|---|
Mean | SD | Median | Mean | SD | Median | p-value * | |
WBC change (/μL) | −4508 | 2444 | −4435 | −4647.69 | 2821 | −4390 | 0.8558 |
Hgb change (g/dL) | −3.00 | 1.80 | −2.95 | −2.49 | 1.77 | −2.25 | 0.3451 |
Platelet change (/μL) | −144,750 | 120,530 | −92,000 | −132,808 | 86,573 | −124,000 | 0.8152 |
GPT change (U/L) | 75.25 | 122.61 | 40.50 | 58.73 | 90.57 | 29.00 | 0.5974 |
Creatinine change (mg/dL) | 0.52 | 0.86 | 0.16 | 0.69 | 1.52 | 0.16 | 0.2354 |
CEA change (ng/mL) | −518.90 | 2472 | −12.31 | 1.41 | 111.32 | −5.56 | 0.4208 |
Body weight change (kg) | −3.71 | 4.27 | −2.20 | −3.76 | 4.60 | −2.55 | 0.9035 |
* Wilcoxon rank sum test; White blood cell (WBC) count change = Minimum WBC count − baseline WBC count; Hemoglobin (Hgb) level change = Minimum Hgb level − baseline Hgb level; Platelet count change = Minimum platelet count − baseline platelet count; glutamic-pyruvic transaminase (GPT) level change = Maximum GPT level − baseline GPT level; creatinine level change = Maximum creatinine level − baseline creatinine level; carcinoembryonic antigen (CEA) level change = last CEA level − baseline CEA level; body weight change = minimum body weight − baseline body weight.